These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 3388655)
1. Importance of early treatment of transitional cell carcinoma of prostatic ducts. Wishnow KI; Ro JY Urology; 1988 Jul; 32(1):11-2. PubMed ID: 3388655 [TBL] [Abstract][Full Text] [Related]
2. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens]. Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661 [TBL] [Abstract][Full Text] [Related]
3. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214 [TBL] [Abstract][Full Text] [Related]
4. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ]. Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679 [TBL] [Abstract][Full Text] [Related]
6. Laparoscopic radical cystoprostatectomy: our experience in a consecutive series of 10 patients with a 3 years follow-up. Simonato A; Gregori A; Lissiani A; Bozzola A; Galli S; Gaboardi F Eur Urol; 2005 Jun; 47(6):785-90; discussion 790-2. PubMed ID: 15925074 [TBL] [Abstract][Full Text] [Related]
7. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. Reese JH; Freiha FS; Gelb AB; Lum BL; Torti FM J Urol; 1992 Jan; 147(1):92-5. PubMed ID: 1729557 [TBL] [Abstract][Full Text] [Related]
8. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer. Lerner SP; Shen S Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459 [TBL] [Abstract][Full Text] [Related]
9. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114 [TBL] [Abstract][Full Text] [Related]
10. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360 [TBL] [Abstract][Full Text] [Related]
11. [Prostatic urothelial location of a tumor of the bladder]. Coulange C; Lechevallier E; de Fromont M Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731 [TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cheville JC; Dundore PA; Bostwick DG; Lieber MM; Batts KP; Sebo TJ; Farrow GM Cancer; 1998 Feb; 82(4):703-7. PubMed ID: 9477103 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection. Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219 [TBL] [Abstract][Full Text] [Related]
14. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens. Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289 [TBL] [Abstract][Full Text] [Related]
15. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice]. Huguet J Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044 [TBL] [Abstract][Full Text] [Related]
16. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. Clark PE; Stein JP; Groshen SG; Miranda G; Cai J; Lieskovsky G; Skinner DG J Urol; 2004 Oct; 172(4 Pt 1):1342-7. PubMed ID: 15371837 [TBL] [Abstract][Full Text] [Related]